Tag archive for ‘GALACTIC-HF phase 3 trial of omecamtiv in advanced heart failure’
A New Note on Cytokinetics with a Focus on Omecamtiv
Cytokinetics and its partner Amgen have guided that topline data from the GALACTIC-HF phase 3 trial of omecamtiv in advanced heart failure will be released in 4Q, 2020. The promise of omecamtiv has been the driving force for my long standing buy recommendation of Cytokinetics and is the overwhelming factor driving the current stock price. […]